LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?

LifeMD (LFMD) partnered with AT&T to offer free virtual-health memberships to 29 million eligible customers in 11 states, with a nationwide expansion planned for 2027. The $19 monthly fee is waived, but services like visits and prescriptions remain payable. LifeMD aims to convert access into recurring demand for paid care, potentially reducing acquisition costs and benefiting from repeat consultations. The phased rollout allows for measuring enrollment and utilization before expansion.

Original reporting
Published Sep 20, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 20, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients? — source image
Decision brief

The 30-second read

$LFMDNeutralMed
01

Why it matters

The partnership creates a large addressable audience but hinges on conversion rates; the financial terms remain opaque, adding risk.

02

Market read

Introduces a potentially significant distribution channel for LifeMD, with uncertain near‑term revenue impact.

03

What to watch

AT&T's per‑lead fee structure and state‑by‑state regulatory constraints could limit scalability.

Relevance 7/10Novelty 7/10Timing: September 15 announcement

Background

LifeMD (LFMD) is a telehealth provider that recently filed an 8‑K detailing a new partnership with AT&T to offer free memberships to eligible customers.

Company-level read

Ticker impact

$LFMDNeutralMedium confidence
Context

LifeMD announced an exclusive partnership with AT&T to offer free virtual‑health memberships to 29 million customers, creating a new distribution channel.

Expected impact

Potential upside if paid‑patient conversion exceeds acquisition cost; downside if utilization remains low.

Evidence & confidence

Partnership size is large but fee per lead is undisclosed, making financial impact uncertain.

Market effects

May boost the telehealth and digital health sector as a model for carrier‑based distribution.

Primarily U.S. market, with potential ripple to other telecom‑health collaborations.

Limited to U.S. investors; partnership does not affect broader macro trends.

Counterpoint

If enrollment does not translate to paid visits, the partnership could increase marketing spend without revenue benefit.

Key entities

  • LifeMD, Inc.

    Telehealth provider entering partnership with AT&T.

  • AT&T Inc.

    Telecom carrier providing the customer base for the partnership.

Related articles

$LFMDMed

LifeMD Nov 2026 slides: platform scale grows amid revenue reset

LifeMD (LFMD) presented its investor deck, highlighting revenue growth from $11M in 2019 to an expected $190M in 2026. Q3 revenue missed expectations at $44.6M, and the stock fell 17.59%. The company emphasized its telehealth platform's scale, AI integration, and nationwide pharmacy infrastructure, serving 350,000 active patients. LifeMD reset 2026 guidance to $188M-$191M revenue and negative EBITDA, citing delayed GLP-1 fulfillment and reduced marketing.

$LFMDMed

Why is LifeMD stock sliding today?

LifeMD (LFMD) stock fell 9.4% after reporting Q3 2026 revenue of $44.6M, missing estimates of $48.9M. The company cut its full-year revenue outlook to $188M-$191M and widened its EBITDA loss forecast. Additionally, an accounting investigation and securities inquiry weighed on sentiment.

$LFMDMed

LifeMD Reports Third Quarter 2026 Results

LifeMD, Inc. (LFMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 LifeMD Reports Third Quarter 2026 Results ● Third quarter 2026 revenue of $44.6 million; adjusted EBITDA loss of approximately $0.4 million, within the Company’s guidance range of negative $1 million to positive $2 million. ● Adjusted EBITDA improved approximately $3

$TMed

AT&T Waives $19 LifeMD Fee for 100 Million Wireless and Fiber Customers

AT&T is partnering with LifeMD to waive its $19 monthly membership fee for over 100 million wireless and fiber customers, making it the first carrier to bundle no-cost virtual healthcare access. The rollout begins in 11 states, with the rest following in January 2027. LifeMD (LFMD) provides telehealth services, and AT&T aims to enhance customer retention. AT&T's stock is valued at $29.03 per share, with projected slight earnings declines due to heavy capital spending.

$LFMDMedAI 9/10

LifeMD (LFMD) Q2 2026 Earnings Call Transcript

LifeMD (LFMD) reported Q2 2026 revenue of $47.3M, within guidance ($47M-$50M) but down 4% YoY, and an adjusted EBITDA loss of about $3.5M. Full-year revenue guidance was cut to $205.5M-$212.5M and adjusted EBITDA to negative $6M to breakeven. Active subscribers were 356,000. Cash was $25.1M.